Literature DB >> 24997480

MLV based viral-like-particles for delivery of toxic proteins and nuclear transcription factors.

Dai-Tze Wu1, Monica J Roth2.   

Abstract

We have developed nanoparticles based on Murine Leukemia Virus virus-like-particles (VLPs) that efficiently deliver therapeutic bioactive proteins in their native state into target cells. Nuclear transcription factors and toxic proteins were incorporated into the VLPs from stable producer cells without transducing viral-encoded genetic material. Delivery of nuclear transcription factors required incorporation of nuclear export signals (NESs) into the vector backbone for the efficient formation of VLPs. In the presence of an appropriate targeting Env glycoprotein, transcription factors delivered and activated nuclear transcription in the target cells. Additionally, we show delivery of the bacterial toxin, MazF, which is an ACA-specific mRNA interferase resulted in the induction of cell death. The stable producer cells are protected from the toxin through co-expression of the anti-toxin MazE and continuously released MazF incorporating VLPs. This highly adaptable platform can be harnessed to alter and regulate cellular processes by bioactive protein delivery.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacterial toxin; Intracellular delivery; Protein transduction; Transcriptional factors; Viral-like particles

Mesh:

Substances:

Year:  2014        PMID: 24997480      PMCID: PMC4139071          DOI: 10.1016/j.biomaterials.2014.06.006

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  47 in total

1.  Protein transduction from retroviral Gag precursors.

Authors:  Christine Voelkel; Melanie Galla; Tobias Maetzig; Eva Warlich; Johannes Kuehle; Daniela Zychlinski; Juergen Bode; Tobias Cantz; Axel Schambach; Christopher Baum
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

2.  Consideration of the three-dimensional structure of core shells (capsids) in spherical retroviruses.

Authors:  Milan V Nermut; Barbara Mulloy
Journal:  Micron       Date:  2006-12-19       Impact factor: 2.251

3.  Identification of a retroviral receptor used by an envelope protein derived by peptide library screening.

Authors:  Anindita Sarangi; Keith Bupp; Monica J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-20       Impact factor: 11.205

4.  Selective and nonselective packaging of cellular RNAs in retrovirus particles.

Authors:  Samuel J Rulli; Catherine S Hibbert; Jane Mirro; Thoru Pederson; Shyam Biswal; Alan Rein
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

5.  Single-round selection yields a unique retroviral envelope utilizing GPR172A as its host receptor.

Authors:  Peter M Mazari; Daniela Linder-Basso; Anindita Sarangi; Yehchung Chang; Monica J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-23       Impact factor: 11.205

Review 6.  mRNA interferases, sequence-specific endoribonucleases from the toxin-antitoxin systems.

Authors:  Yoshihiro Yamaguchi; Masayori Inouye
Journal:  Prog Mol Biol Transl Sci       Date:  2009       Impact factor: 3.622

7.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.

Authors:  Salima Hacein-Bey-Abina; Alexandrine Garrigue; Gary P Wang; Jean Soulier; Annick Lim; Estelle Morillon; Emmanuelle Clappier; Laure Caccavelli; Eric Delabesse; Kheira Beldjord; Vahid Asnafi; Elizabeth MacIntyre; Liliane Dal Cortivo; Isabelle Radford; Nicole Brousse; François Sigaux; Despina Moshous; Julia Hauer; Arndt Borkhardt; Bernd H Belohradsky; Uwe Wintergerst; Maria C Velez; Lily Leiva; Ricardo Sorensen; Nicolas Wulffraat; Stéphane Blanche; Frederic D Bushman; Alain Fischer; Marina Cavazzana-Calvo
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

8.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

9.  Development of an enzyme-linked immunosorbent assay based on the murine leukemia virus p30 capsid protein.

Authors:  Dai-Tze Wu; Sriram Aiyer; Rodrigo A Villanueva; Monica J Roth
Journal:  J Virol Methods       Date:  2013-06-26       Impact factor: 2.014

10.  A dominant-negative form of mouse SOX2 induces trophectoderm differentiation and progressive polyploidy in mouse embryonic stem cells.

Authors:  Jun Li; Guangjin Pan; Kai Cui; Yuwen Liu; Shaobin Xu; Duanqing Pei
Journal:  J Biol Chem       Date:  2007-05-15       Impact factor: 5.157

View more
  8 in total

1.  Role of Cysteines in Stabilizing the Randomized Receptor Binding Domains within Feline Leukemia Virus Envelope Proteins.

Authors:  Leonardo Valdivieso-Torres; Anindita Sarangi; Jillian Whidby; Joseph Marcotrigiano; Monica J Roth
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

2.  Virus-Like Particles Derived from HIV-1 for Delivery of Nuclear Proteins: Improvement of Production and Activity by Protein Engineering.

Authors:  Marc-André Robert; Viktoria Lytvyn; Francis Deforet; Rénald Gilbert; Bruno Gaillet
Journal:  Mol Biotechnol       Date:  2017-01       Impact factor: 2.695

3.  Phosphorylation of mouse SAMHD1 regulates its restriction of human immunodeficiency virus type 1 infection, but not murine leukemia virus infection.

Authors:  Feifei Wang; Corine St Gelais; Suresh de Silva; Hong Zhang; Yu Geng; Caitlin Shepard; Baek Kim; Jacob S Yount; Li Wu
Journal:  Virology       Date:  2015-11-12       Impact factor: 3.616

4.  Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins.

Authors:  Samagya Banskota; Aditya Raguram; Susie Suh; Samuel W Du; Jessie R Davis; Elliot H Choi; Xiao Wang; Sarah C Nielsen; Gregory A Newby; Peyton B Randolph; Mark J Osborn; Kiran Musunuru; Krzysztof Palczewski; David R Liu
Journal:  Cell       Date:  2022-01-11       Impact factor: 66.850

Review 5.  Virus-like Particles as Nanocarriers for Intracellular Delivery of Biomolecules and Compounds.

Authors:  Junyao He; Linying Yu; Xiaodi Lin; Xiaoyan Liu; Yanming Zhang; Fan Yang; Wen Deng
Journal:  Viruses       Date:  2022-08-28       Impact factor: 5.818

Review 6.  Intracellular targeting with engineered proteins.

Authors:  Shane Miersch; Sachdev S Sidhu
Journal:  F1000Res       Date:  2016-08-10

7.  Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping.

Authors:  Peter Gee; Mandy S Y Lung; Yuya Okuzaki; Noriko Sasakawa; Takahiro Iguchi; Yukimasa Makita; Hiroyuki Hozumi; Yasutomo Miura; Lucy F Yang; Mio Iwasaki; Xiou H Wang; Matthew A Waller; Nanako Shirai; Yasuko O Abe; Yoko Fujita; Kei Watanabe; Akihiro Kagita; Kumiko A Iwabuchi; Masahiko Yasuda; Huaigeng Xu; Takeshi Noda; Jun Komano; Hidetoshi Sakurai; Naoto Inukai; Akitsu Hotta
Journal:  Nat Commun       Date:  2020-03-13       Impact factor: 14.919

Review 8.  Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology.

Authors:  Ana F Rodrigues; Hugo R Soares; Miguel R Guerreiro; Paula M Alves; Ana S Coroadinha
Journal:  Biotechnol J       Date:  2015-07-24       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.